3 articles
Stanford researchers develop a universal nasal spray vaccine, tested in animals, that primes lung immune cells to broadly fight viruses, bacteria, and allergens, marking a radical new approach to immunization.
A universal nasal spray vaccine tested in animals could protect against many viruses, bacteria, and allergies by putting lung immune cells on high alert, marking a radical new approach. Human trials are needed.
A universal nasal spray vaccine tested in animals could protect against many viruses, bacteria, and allergies by putting lung immune cells on high alert. Experts call it exciting but early-stage research.